Neuroprotective Potency of Neolignans in Magnolia officinalis Cortex Against Brain Disorders

In recent years, neurological diseases including Alzheimer’s disease, Parkinson’s disease and stroke are one of the main causes of death in the world. At the same time, the incidence of psychiatric disorders including depression and anxiety has been increasing. Accumulating elderly and stressed peop...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in pharmacology 2022-06, Vol.13, p.857449-857449
Main Authors: Zhu, Shun, Liu, Fang, Zhang, Ruiyuan, Xiong, Zongxiang, Zhang, Qian, Hao, Li, Chen, Shiyin
Format: Article
Language:English
Subjects:
brain disorders
Magnolia officinalis
multiple pathways
neolignans
neuroprotective effect
Pharmacology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c442t-efa13ce7fe91285bd2a7ff1a1a586c64bdf55a114aa6ee50d130765af3e8e8773
cites cdi_FETCH-LOGICAL-c442t-efa13ce7fe91285bd2a7ff1a1a586c64bdf55a114aa6ee50d130765af3e8e8773
container_end_page 857449
container_issue
container_start_page 857449
container_title Frontiers in pharmacology
container_volume 13
creator Zhu, Shun
Liu, Fang
Zhang, Ruiyuan
Xiong, Zongxiang
Zhang, Qian
Hao, Li
Chen, Shiyin
description In recent years, neurological diseases including Alzheimer’s disease, Parkinson’s disease and stroke are one of the main causes of death in the world. At the same time, the incidence of psychiatric disorders including depression and anxiety has been increasing. Accumulating elderly and stressed people suffer from these brain disorders, which is undoubtedly a huge burden on the modern aging society. Neolignans, the main active ingredients in Magnolia officinalis cortex, were reported to have neuroprotective effects. In addition, the key bioactive ingredients of neolignans, magnolol (1) and honokiol (2) , were proved to prevent and treat neurological diseases and psychiatric disorders by protecting nerve cells and brain microvascular endothelial cells (BMECs). Furthermore, neolignans played a role in protecting nerve cells via regulation of neuronal function, suppression of neurotoxicity, etc. This review summarizes the neuroprotective effect, primary mechanisms of the leading neolignans and provides new prospects for the treatment of brain disorders in the future.
doi_str_mv 10.3389/fphar.2022.857449
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_b007d8cd51f049a5b75d499a47923e8a</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_b007d8cd51f049a5b75d499a47923e8a</doaj_id><sourcerecordid>2685040154</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-efa13ce7fe91285bd2a7ff1a1a586c64bdf55a114aa6ee50d130765af3e8e8773</originalsourceid><addsrcrecordid>eNpVkctuFDEQRVsIRKKQD2DXSzYz-P3YIIXhkUghsIAdklVtlzuOeuzB7onI39PJRBGpTd2qujq1uF33lpI158a-j7trqGtGGFsbqYWwL7pjqhRfWUPZy__0UXfa2g1ZilvLlXjdHXGpjdBSHne_r3Bfy66WGf2cbrH_sajs7_oS-yssUxoz5Nan3H-DMS8zLJeYfMowpdZvSp3xb382Qspt7j_WpfefUis1YG1vulcRpoanj_2k-_Xl88_N-ery-9eLzdnlygvB5hVGoNyjjmgpM3IIDHSMFChIo7wSQ4hSAqUCQCFKEignWkmIHA0arflJd3HghgI3blfTFuqdK5Dcw6LU0UGdk5_QDYToYHyQNBJhQQ5aBmEtCG3ZgoOF9eHA2u2HLQaPea4wPYM-v-R07cZy6ywTQhO1AN49Amr5s8c2u21qHqcJMpZ9c0wZSQShUixWerD6WlqrGJ_eUOLuQ3YPIbv7kN0hZP4Ph8-cIQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2685040154</pqid></control><display><type>article</type><title>Neuroprotective Potency of Neolignans in Magnolia officinalis Cortex Against Brain Disorders</title><source>NCBI_PubMed Central（免费）</source><creator>Zhu, Shun ; Liu, Fang ; Zhang, Ruiyuan ; Xiong, Zongxiang ; Zhang, Qian ; Hao, Li ; Chen, Shiyin</creator><creatorcontrib>Zhu, Shun ; Liu, Fang ; Zhang, Ruiyuan ; Xiong, Zongxiang ; Zhang, Qian ; Hao, Li ; Chen, Shiyin</creatorcontrib><description>In recent years, neurological diseases including Alzheimer’s disease, Parkinson’s disease and stroke are one of the main causes of death in the world. At the same time, the incidence of psychiatric disorders including depression and anxiety has been increasing. Accumulating elderly and stressed people suffer from these brain disorders, which is undoubtedly a huge burden on the modern aging society. Neolignans, the main active ingredients in Magnolia officinalis cortex, were reported to have neuroprotective effects. In addition, the key bioactive ingredients of neolignans, magnolol (1) and honokiol (2) , were proved to prevent and treat neurological diseases and psychiatric disorders by protecting nerve cells and brain microvascular endothelial cells (BMECs). Furthermore, neolignans played a role in protecting nerve cells via regulation of neuronal function, suppression of neurotoxicity, etc. This review summarizes the neuroprotective effect, primary mechanisms of the leading neolignans and provides new prospects for the treatment of brain disorders in the future.</description><identifier>ISSN: 1663-9812</identifier><identifier>EISSN: 1663-9812</identifier><identifier>DOI: 10.3389/fphar.2022.857449</identifier><identifier>PMID: 35784755</identifier><language>eng</language><publisher>Frontiers Media S.A</publisher><subject>brain disorders ; Magnolia officinalis ; multiple pathways ; neolignans ; neuroprotective effect ; Pharmacology</subject><ispartof>Frontiers in pharmacology, 2022-06, Vol.13, p.857449-857449</ispartof><rights>Copyright © 2022 Zhu, Liu, Zhang, Xiong, Zhang, Hao and Chen. 2022 Zhu, Liu, Zhang, Xiong, Zhang, Hao and Chen</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-efa13ce7fe91285bd2a7ff1a1a586c64bdf55a114aa6ee50d130765af3e8e8773</citedby><cites>FETCH-LOGICAL-c442t-efa13ce7fe91285bd2a7ff1a1a586c64bdf55a114aa6ee50d130765af3e8e8773</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244706/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244706/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>Zhu, Shun</creatorcontrib><creatorcontrib>Liu, Fang</creatorcontrib><creatorcontrib>Zhang, Ruiyuan</creatorcontrib><creatorcontrib>Xiong, Zongxiang</creatorcontrib><creatorcontrib>Zhang, Qian</creatorcontrib><creatorcontrib>Hao, Li</creatorcontrib><creatorcontrib>Chen, Shiyin</creatorcontrib><title>Neuroprotective Potency of Neolignans in Magnolia officinalis Cortex Against Brain Disorders</title><title>Frontiers in pharmacology</title><description>In recent years, neurological diseases including Alzheimer’s disease, Parkinson’s disease and stroke are one of the main causes of death in the world. At the same time, the incidence of psychiatric disorders including depression and anxiety has been increasing. Accumulating elderly and stressed people suffer from these brain disorders, which is undoubtedly a huge burden on the modern aging society. Neolignans, the main active ingredients in Magnolia officinalis cortex, were reported to have neuroprotective effects. In addition, the key bioactive ingredients of neolignans, magnolol (1) and honokiol (2) , were proved to prevent and treat neurological diseases and psychiatric disorders by protecting nerve cells and brain microvascular endothelial cells (BMECs). Furthermore, neolignans played a role in protecting nerve cells via regulation of neuronal function, suppression of neurotoxicity, etc. This review summarizes the neuroprotective effect, primary mechanisms of the leading neolignans and provides new prospects for the treatment of brain disorders in the future.</description><subject>brain disorders</subject><subject>Magnolia officinalis</subject><subject>multiple pathways</subject><subject>neolignans</subject><subject>neuroprotective effect</subject><subject>Pharmacology</subject><issn>1663-9812</issn><issn>1663-9812</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkctuFDEQRVsIRKKQD2DXSzYz-P3YIIXhkUghsIAdklVtlzuOeuzB7onI39PJRBGpTd2qujq1uF33lpI158a-j7trqGtGGFsbqYWwL7pjqhRfWUPZy__0UXfa2g1ZilvLlXjdHXGpjdBSHne_r3Bfy66WGf2cbrH_sajs7_oS-yssUxoz5Nan3H-DMS8zLJeYfMowpdZvSp3xb382Qspt7j_WpfefUis1YG1vulcRpoanj_2k-_Xl88_N-ery-9eLzdnlygvB5hVGoNyjjmgpM3IIDHSMFChIo7wSQ4hSAqUCQCFKEignWkmIHA0arflJd3HghgI3blfTFuqdK5Dcw6LU0UGdk5_QDYToYHyQNBJhQQ5aBmEtCG3ZgoOF9eHA2u2HLQaPea4wPYM-v-R07cZy6ywTQhO1AN49Amr5s8c2u21qHqcJMpZ9c0wZSQShUixWerD6WlqrGJ_eUOLuQ3YPIbv7kN0hZP4Ph8-cIQ</recordid><startdate>20220616</startdate><enddate>20220616</enddate><creator>Zhu, Shun</creator><creator>Liu, Fang</creator><creator>Zhang, Ruiyuan</creator><creator>Xiong, Zongxiang</creator><creator>Zhang, Qian</creator><creator>Hao, Li</creator><creator>Chen, Shiyin</creator><general>Frontiers Media S.A</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20220616</creationdate><title>Neuroprotective Potency of Neolignans in Magnolia officinalis Cortex Against Brain Disorders</title><author>Zhu, Shun ; Liu, Fang ; Zhang, Ruiyuan ; Xiong, Zongxiang ; Zhang, Qian ; Hao, Li ; Chen, Shiyin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-efa13ce7fe91285bd2a7ff1a1a586c64bdf55a114aa6ee50d130765af3e8e8773</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>brain disorders</topic><topic>Magnolia officinalis</topic><topic>multiple pathways</topic><topic>neolignans</topic><topic>neuroprotective effect</topic><topic>Pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhu, Shun</creatorcontrib><creatorcontrib>Liu, Fang</creatorcontrib><creatorcontrib>Zhang, Ruiyuan</creatorcontrib><creatorcontrib>Xiong, Zongxiang</creatorcontrib><creatorcontrib>Zhang, Qian</creatorcontrib><creatorcontrib>Hao, Li</creatorcontrib><creatorcontrib>Chen, Shiyin</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhu, Shun</au><au>Liu, Fang</au><au>Zhang, Ruiyuan</au><au>Xiong, Zongxiang</au><au>Zhang, Qian</au><au>Hao, Li</au><au>Chen, Shiyin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neuroprotective Potency of Neolignans in Magnolia officinalis Cortex Against Brain Disorders</atitle><jtitle>Frontiers in pharmacology</jtitle><date>2022-06-16</date><risdate>2022</risdate><volume>13</volume><spage>857449</spage><epage>857449</epage><pages>857449-857449</pages><issn>1663-9812</issn><eissn>1663-9812</eissn><abstract>In recent years, neurological diseases including Alzheimer’s disease, Parkinson’s disease and stroke are one of the main causes of death in the world. At the same time, the incidence of psychiatric disorders including depression and anxiety has been increasing. Accumulating elderly and stressed people suffer from these brain disorders, which is undoubtedly a huge burden on the modern aging society. Neolignans, the main active ingredients in Magnolia officinalis cortex, were reported to have neuroprotective effects. In addition, the key bioactive ingredients of neolignans, magnolol (1) and honokiol (2) , were proved to prevent and treat neurological diseases and psychiatric disorders by protecting nerve cells and brain microvascular endothelial cells (BMECs). Furthermore, neolignans played a role in protecting nerve cells via regulation of neuronal function, suppression of neurotoxicity, etc. This review summarizes the neuroprotective effect, primary mechanisms of the leading neolignans and provides new prospects for the treatment of brain disorders in the future.</abstract><pub>Frontiers Media S.A</pub><pmid>35784755</pmid><doi>10.3389/fphar.2022.857449</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1663-9812
ispartof Frontiers in pharmacology, 2022-06, Vol.13, p.857449-857449
issn 1663-9812
1663-9812
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_b007d8cd51f049a5b75d499a47923e8a
source NCBI_PubMed Central（免费）
subjects brain disorders
Magnolia officinalis
multiple pathways
neolignans
neuroprotective effect
Pharmacology
title Neuroprotective Potency of Neolignans in Magnolia officinalis Cortex Against Brain Disorders
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T12%3A50%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neuroprotective%20Potency%20of%20Neolignans%20in%20Magnolia%20officinalis%20Cortex%20Against%20Brain%20Disorders&rft.jtitle=Frontiers%20in%20pharmacology&rft.au=Zhu,%20Shun&rft.date=2022-06-16&rft.volume=13&rft.spage=857449&rft.epage=857449&rft.pages=857449-857449&rft.issn=1663-9812&rft.eissn=1663-9812&rft_id=info:doi/10.3389/fphar.2022.857449&rft_dat=%3Cproquest_doaj_%3E2685040154%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c442t-efa13ce7fe91285bd2a7ff1a1a586c64bdf55a114aa6ee50d130765af3e8e8773%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2685040154&rft_id=info:pmid/35784755&rfr_iscdi=true